veterinary medicine
new regenerative medicine
veterinary regenerative medicine
new advanced material
innovative regenerative medicine treatment
new SME
market potential
cartilage regeneration
marketed products
tested products
market feasibility study
SME ArtinVet
ArtinVet Innovative Therapies
osteoarthritis
international market positioning
cure
horses
dogs
largest market share
HR007 production
regenerative intra-articular product of non-bovine origin
unique multiple GAGs rich material of natural origin
Successful completion of Phase
regeneration of joints
joint cartilage
therapies available
treatment efficiency
administration of glycosaminoglycans
main objective of VetBiomat
product authorization procedures
Successful accomplishment of phases
novel
complex
inclusion
clinical studies
chondrocytes
major economic problem
larger project
SEM Instrument
superior qualities
robust business plan
mesenchymal cells migration
sound scientific evidence of efficacy
corticosteroids
symptoms
funding
progressive deterioration
unmet need
analgesics
NSAIDs
different routes
commercial treatments
growth
disease
nutraceuticals
use